Investigating genetic mutations that make mice resistant to cancer
Cancer Resistant Mice
This study is looking at how certain genetic changes in mice might help them fight off deadly cancers, which could lead to new ways to treat cancer in people.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project ID | NIH-10986126 on NIH RePORTER |
What this research studies
This research explores whether specific genetic mutations can provide strong resistance to lethal cancers in mice. By using a method called ENU mutagenesis, researchers have created a large population of genetically modified mice to identify mutations that may hinder tumor growth and immune evasion. The study aims to uncover how these mutations affect the body's response to cancer, which could lead to new therapeutic targets for cancer treatment. The findings may help in understanding the genetic basis of cancer resistance and inform future human therapies.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research would be individuals with a family history of cancer or those at high risk for developing cancer due to genetic factors.
Not a fit: Patients with advanced cancer or those who do not have a genetic predisposition to cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for cancer prevention and treatment in humans.
How similar studies have performed: Other research has shown success in identifying genetic factors that influence cancer resistance, making this approach promising.
Where this research is happening
Dallas, United States
- Ut Southwestern Medical Center — Dallas, United States (Active)
Researchers
- Principal investigator: Beutler, Bruce a — Ut Southwestern Medical Center
- Study coordinator: Beutler, Bruce a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.